Two major cardiovascular trials, ZEUS and Lp(a)HORIZON, demonstrated that successfully altering a biological marker doesn't guarantee improved patient outcomes.
Two major cardiovascular trials, ZEUS and Lp(a)HORIZON, demonstrated that successfully altering a biological marker doesn't guarantee improved patient outcomes.